Hydralazine 是一种具有口服活性的降压药，通过放松动脉血管平滑肌细胞层，直接降低外周阻力。Hydralazine 具有抗氧化活性，抑制活性氧 (ROS)释放和 O2·-生成，IC50分别为 9.53 mM 和 1.19 mM。
| 生物活性 | Hydralazine is a orally active antihypertensive agent, reduces peripheral resistance directly by relaxing the smooth muscle cell layer in arterial vessel. Hydralazine has antioxidant activity, as well as inhibitsreactive oxygen species(ROS)release and O2·-generation with anIC50value of 9.53 mM and 1.19 mM, respectively[1][2]. |
| IC50& Target | IC50: 9.53 mM (ROS), 1.19 mM (O2·-)[1] |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
